Video Experimental Relacionado

Updated: Nov 21, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

Resultados mixtos en el ensayo de terapia CAR-T para neuroblastoma pediátrico

Jennifer Abbasi

    JAMA
    |January 12, 2021
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    Videos de Experimentos Relacionados

    Last Updated: Nov 21, 2025

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
    09:34

    Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

    Published on: February 17, 2022

    3.6K
    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
    05:22

    Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

    Published on: February 24, 2023

    3.8K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.8K

    Videos de Conceptos Relacionados

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.5K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.5K
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ACERCA DE JoVE
    Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
    AUTORES
    Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
    BIBLIOTECARIOS
    TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
    INVESTIGACIÓN
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
    EDUCACIÓN
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
    Términos y Condiciones de Uso
    Política de Privacidad
    Políticas
    Jove
    Visualize
    Contáctanos